Skip to main content
OpenTrials

Clinical trial condition

Neisseriaceae Infections

Explore clinical trials studying Neisseriaceae Infections. Study availability and eligibility vary by location and protocol.

400 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Neisseriaceae Infections trial results

Completed

Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children

NCT01900899

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Espoo Vaccine Research Clinic Espoo, Finland
  • Tampereen yliopisto/ Etela-Helsingin rokotetutkimusklinikka Helsinki, Finland
  • Helsinki East Vaccine Research Clinic Helsinki, Finland
  • Tampereen Yliopisto/ Jarvenpaan rokotetutkimusklinikka Jarvenpaa, Finland
View Trial Details
Completed

Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

NCT01682876

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +5 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Sacramento, California, United States
  • GSK Investigational Site Lake Mary, Florida, United States
  • GSK Investigational Site Marietta, Georgia, United States
View all 19 locations
View Trial Details
Completed

The Long-term Antibody Persistence of MenACWY-TT Vaccine (PF-06866681) Versus Meningitec(Registered) or Mencevax(Registered) ACWY in Healthy Adolescents and Adults and a Booster Dose of MenACWY-TT Administered 10 Years Post Primary Vaccination

NCT01962207

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Espoo Vaccine Research Clinic Espoo, Finland
  • South Helsinki Vaccine Research Clinic Helsinki, Finland
  • Helsinki East Vaccine Research Clinic Helsinki, Finland
  • Jarvenpaa Vaccine Research Clinic Jarvenpaa, Finland
View Trial Details
Completed

Performance of Nucleic Acid Amplification Tests for the Detection of NG and CT

NCT02870101

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Chlamydia Trachomatis Infection, +19 more
Locations
  • AIDS Health Foundation - Hollywood Hollywood, California, United States
  • Los Angeles LGBT Clinic Los Angeles, California, United States
  • Denver Health and Hospital Authority Denver, Colorado, United States
  • AIDS Healthcare Foundation - Miami Miami, Florida, United States
View Trial Details
Completed

Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life

NCT00625677

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
Locations
  • Health Protection Agency Gloucester, United Kingdom
  • Health Protection Agency London, United Kingdom
View Trial Details
Completed

Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine Administered to Healthy Adolescents According to Different Vaccination Schedules

NCT00661713

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Site 13: Liceo Diego Aracena de Lo Barnechea Monseñor Escrivá de Balaguer 14630, Lo Barnechea, Santiago Metropolitan, Chile
  • Site 41: Colegio Antonio Hermida Fabres Av. Coronel Alejandro Sepúlveda N° 6801, Chile
  • Site 43: Liceo José Victorino Lastarria Av. Miguel Claro N° 32, Chile
  • Site 51: Centro Para vacunas en Desarrollo. Hospital de Niños Roberto del Rio Av. Prof Zañartu 1085, Chile
View Trial Details

Related conditions